Rajiv Gandhi Cancer Institute and Research Center, New Delhi (RGCI) have installed the first-ever Made-in-India Surgical Robotic System, SSI-Mantra, devised by the new-age Indian med-tech start-up SS Innovations.
The measures include easing norms for FPI investment in the debt market, and increasing the External Commercial Borrowing (ECB) limit under the automatic route from USD750 million or its equivalent per financial year to USD 1.5 billion.
EXAMIANS